Phenolic and Steroidal Metabolites from the Cultivated Edible Inonotus Hispidus Mushroom and Their Bioactivities

Rong-Wei Kou,Shuang-Tian Du,Bing Xia,Qiang Zhang,Xia Yin,Jin-Ming Gao
DOI: https://doi.org/10.1021/acs.jafc.0c06822
IF: 6.1
2021-01-01
Journal of Agricultural and Food Chemistry
Abstract:A chemical study on the fruiting bodies of cultivated edible mushroom Inonotus hispidus resulted in 14 metabolites including three new hispolon congeners, named inonophenols A-B and one new lanostane triterpenoid, named inonoterpene A. These structures were identified by NMR, high-resolution electrospray ionization mass spectrometry (HRESIMS), and electronic circular dichroism (ECD) data analysis. All metabolites were assessed for neurotrophic, anti-inflammatory, and antioxidative activities. Among them, inonophenols B and C were the most active in promoting PC-12 cell neurite outgrowth at a concentration of 10 mu M. The phenolic derivatives reduced NO generation by lipopolysaccharide (LPS)-induced BV-2 microglial cells by suppressing the expression of toll-like receptor-4 (TLR-4) and the nuclear factor-kappa-B (NF-kappa B) signaling pathway as well as the inflammatory mediators including inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Moreover, the phenolics showed antioxidant effects in DPPH scavenging assay with the IC50 values of 9.82-21.43 mu M. These findings showed that I. hispidus may be a new source of neurotrophic and protective agents against neurodegenerative disorders.
What problem does this paper attempt to address?